Cellulitis. Cellulitis and acute lymphangitis
Conditions
Interventions
Intervention 1: Intervention group: The intervention group received Cefazolin (1.5-1 g intravenously every 8 hours) and Naproxen (500 mg orally every 12 hours) until the end of hospitalization. The dr
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Hospitalized patients with a diagnosis of cellulitis Age over 18 years Willingness to participate in this clinical trial
Exclusion criteria
Exclusion criteria: Allergy to Penicillin, Cefazolin or Naproxen Pregnant women Immunodeficiency Patients with mucocutaneous diseases Patients with kidney diseases Patients with vascular catheters Patients suspected of having septic arthritis or osteomyelitis Patients with infected diabetic foot ulcers Bite or the presence of a foreign body in the wound Perianal cellulitis Injecting substance abuse Hospitalization during the last three months Chronic hemodialysis patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Erythema. Timepoint: Before the intervention, 2, 3, and 5 to 7 days after the start of the intervention. Method of measurement: Trained doctor report.;Warmth. Timepoint: Before the intervention, 2, 3, and 5 to 7 days after the start of the intervention. Method of measurement: Trained doctor report.;Tenderness. Timepoint: Before the intervention, 2, 3, and 5 to 7 days after the start of the intervention. Method of measurement: Trained doctor report.;Body temperature. Timepoint: Before the intervention, 2, 3, and 5 to 7 days after the start of the intervention. Method of measurement: Using a mercury thermometer.;Reduce exudate secretion from the wound. Timepoint: Before the intervention, 2, 3, and 5 to 7 days after the start of the intervention. Method of measurement: Trained doctor report.;Hospitalization duration. Timepoint: Before the intervention, 2, 3, and 5 to 7 days after the start of the intervention. Method of measurement: Medical record. | — |
Secondary
| Measure | Time frame |
|---|---|
| Epigastric pain. Timepoint: Before the intervention, 2, 3, and 5 to 7 days after the start of the intervention. Method of measurement: Trained doctor report.;Diarreha. Timepoint: Before the intervention, 2, 3, and 5 to 7 days after the start of the intervention. Method of measurement: Trained doctor report.;Itching. Timepoint: Before the intervention, 2, 3, and 5 to 7 days after the start of the intervention. Method of measurement: Trained doctor report.;Skin rash. Timepoint: Before the intervention, 2, 3, and 5 to 7 days after the start of the intervention. Method of measurement: Trained doctor report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSadaf Saket
Shahid Beheshti University of Medical Sciences
Outcome results
None listed